Skip to content

Drug interactions

Lenvatinib + Sofosbuvir-velpatasvir

Severity: Minor

Lenvatinib and Sofosbuvir-velpatasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Velpatasvir inhibits BCRP, but lenvatinib is only a P-gp and BCRP substrate with high bioavailability. Any increase is likely small.

What this interaction means in plain words

Lenvatinib and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lenvatinib belongs to Oncology; Sofosbuvir-velpatasvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Velpatasvir may inhibit intestinal BCRP and P-gp efflux of lenvatinib.

What to do

Monitor for lenvatinib toxicity such as hypertension, proteinuria and diarrhea. Adjust dose per labeling if adverse effects occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenvatinib and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenvatinib with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as minor. Lenvatinib and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Velpatasvir inhibits BCRP, but lenvatinib is only a P-gp and BCRP substrate with high bioavailability. Any increase is likely small.

How serious is the interaction between Lenvatinib and Sofosbuvir-velpatasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for lenvatinib toxicity such as hypertension, proteinuria and diarrhea. Adjust dose per labeling if adverse effects occur.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in